✦ LIBER ✦

Prospective Observational Comparison of Clinical Outcomes Between African-American and Caucasian Patients Receiving Second-Line Treatment With Pemetrexed for Advanced Non–Small-Cell Lung Cancer

✍ Scribed by Pennella, Eduardo; Obasaju, Coleman K.; Pohl, Gerhardt; Peltz, Gerson; Girvan, Allicia C.; Winfree, Katherine B.; Martinez, Betzaida; Marciniak, Martin; Walker, Mark S.; Stepanski, Edward; Schwartzberg, Lee S.; Adjei, Alex

Book ID: 123072134
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 681 KB
Volume: 14
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2013.06.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparison of individualized treatment

A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis

✍ Nelson, Richard E.; Stenehjem, David; Akerley, Wallace 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 815 KB

An indirect comparison of bevacizumab pl

An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia

✍ John Wen-Cheng CHANG; Sumitra THONGPRASERT; Elaine WRIGHT; Kenneth TSANG; Heung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

PCN43 COST COMPARISON OF ERLOTINIB VERSU

PCN43 COST COMPARISON OF ERLOTINIB VERSUS PEMETREXED FOR THE FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN ITALY

✍ S Ravera; S Walzer; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN44 COST COMPARISON OF ERLOTINIB VERSU

PCN44 COST COMPARISON OF ERLOTINIB VERSUS PEMETREXED FOR THE FIRST-LINE MAINTENANCE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN SPAIN

✍ J Castro de Carpeño; AJ Castro-Gómez; S Walzer; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Factors affecting the association betwee

Factors affecting the association between overall survival and progression-free survival in clinical trials of first-line treatment for patients with advanced non-small cell lung cancer

✍ Aboshi, Masayuki; Kaneko, Masayuki; Narukawa, Mamoru 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 339 KB

Cost Effectiveness of EML4-ALK Fusion Te

Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer

✍ Djalalov, S.; Beca, J.; Hoch, J. S.; Krahn, M.; Tsao, M.-S.; Cutz, J.-C.; Leighl 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 306 KB